A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-05-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924015249 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223719347126272 |
|---|---|
| author | Caroline Duineveld Nicole C.A.J. van de Kar Jack F.M. Wetzels |
| author_facet | Caroline Duineveld Nicole C.A.J. van de Kar Jack F.M. Wetzels |
| author_sort | Caroline Duineveld |
| collection | DOAJ |
| format | Article |
| id | doaj-art-8609311dc7f34ee99fd0ecc9d2d287ce |
| institution | OA Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2024-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-8609311dc7f34ee99fd0ecc9d2d287ce2025-08-20T02:05:50ZengElsevierKidney International Reports2468-02492024-05-0195153810.1016/j.ekir.2024.02.1434A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathyCaroline Duineveld0Nicole C.A.J. van de Kar1Jack F.M. Wetzels2Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlands; Correspondence: Caroline Duineveld, Department of Nephrology 464, Radboud University Medical Center, PO BOX 9101, 6500 HB Nijmegen, The Netherlands.Department of Pediatric Nephrology, Radboud University Medical Center, Amalia Children’s Hospital, Radboud Institute for Molecular Life Sciences, Nijmegen, The NetherlandsDepartment of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, The Netherlandshttp://www.sciencedirect.com/science/article/pii/S2468024924015249 |
| spellingShingle | Caroline Duineveld Nicole C.A.J. van de Kar Jack F.M. Wetzels A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy Kidney International Reports |
| title | A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy |
| title_full | A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy |
| title_fullStr | A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy |
| title_full_unstemmed | A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy |
| title_short | A Caution Against the Use of C5b-9 Endothelial Assay to Support Eculizumab Therapy: A response to Maritati et al.: “Eculizumab first” in the management of posttransplant thrombotic microangiopathy |
| title_sort | caution against the use of c5b 9 endothelial assay to support eculizumab therapy a response to maritati et al eculizumab first in the management of posttransplant thrombotic microangiopathy |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924015249 |
| work_keys_str_mv | AT carolineduineveld acautionagainsttheuseofc5b9endothelialassaytosupporteculizumabtherapyaresponsetomaritatietaleculizumabfirstinthemanagementofposttransplantthromboticmicroangiopathy AT nicolecajvandekar acautionagainsttheuseofc5b9endothelialassaytosupporteculizumabtherapyaresponsetomaritatietaleculizumabfirstinthemanagementofposttransplantthromboticmicroangiopathy AT jackfmwetzels acautionagainsttheuseofc5b9endothelialassaytosupporteculizumabtherapyaresponsetomaritatietaleculizumabfirstinthemanagementofposttransplantthromboticmicroangiopathy AT carolineduineveld cautionagainsttheuseofc5b9endothelialassaytosupporteculizumabtherapyaresponsetomaritatietaleculizumabfirstinthemanagementofposttransplantthromboticmicroangiopathy AT nicolecajvandekar cautionagainsttheuseofc5b9endothelialassaytosupporteculizumabtherapyaresponsetomaritatietaleculizumabfirstinthemanagementofposttransplantthromboticmicroangiopathy AT jackfmwetzels cautionagainsttheuseofc5b9endothelialassaytosupporteculizumabtherapyaresponsetomaritatietaleculizumabfirstinthemanagementofposttransplantthromboticmicroangiopathy |